OPKO Health
OPK
₹117.56
Share price
0.00%
Change (1 day)
-1.83%
Change (1 year)
Categories
OPKO Health (OPK) - Cash on Hand
Cash on Hand as of March 2025 : ₹37.96 Billion
According to OPKO Health
's latest financial reports the company has ₹37.96 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
OPKO Health - Cash on Hand chart (from 1996 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | ₹37.05 B | 364.22% |
| 2023-12-31 | ₹7.98 B | -37.03% |
| 2022-12-31 | ₹12.67 B | 26.43% |
| 2021-12-31 | ₹10.02 B | 89.86% |
| 2020-12-31 | ₹5.28 B | -13.33% |
| 2019-12-31 | ₹6.09 B | -9.67% |
| 2018-12-31 | ₹6.74 B | 15.46% |
| 2017-12-31 | ₹5.84 B | -49.05% |
| 2016-12-31 | ₹11.46 B | -10.88% |
| 2015-12-31 | ₹12.86 B | 109.48% |
| 2014-12-31 | ₹6.14 B | -46.49% |
| 2013-12-31 | ₹11.47 B | 666.21% |
| 2012-12-31 | ₹1.49 B | -60.4% |
| 2011-12-31 | ₹3.78 B | 368.63% |
| 2010-12-31 | ₹0.80 B | -59.21% |
| 2009-12-31 | ₹1.97 B | 516.66% |
| 2008-12-31 | ₹0.32 B | -65.01% |
| 2007-12-31 | ₹0.91 B | 17753.98% |
| 2006-12-31 | ₹5.13 M | -98.72% |
| 2005-12-31 | ₹0.40 B | -6.18% |
| 2004-12-31 | ₹0.42 B | -7.45% |
| 2003-12-31 | ₹0.46 B | -40.59% |
| 2002-12-31 | ₹0.77 B | 7.32% |
| 2001-12-31 | ₹0.72 B | -56.22% |
| 2000-12-31 | ₹1.65 B | 1083.11% |
| 1999-12-31 | ₹0.13 B | -51.69% |
| 1998-12-31 | ₹0.28 B | 308.73% |
| 1997-12-31 | ₹70.73 M | -32.15% |
| 1996-12-31 | ₹0.10 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | ₹3.377 T | 8,794.75% | 🇺🇸 USA |
 Abbott Laboratories ABT | ₹595.97 B | 1,469.73% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | ₹727.06 B | 1,815.00% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | ₹147.77 B | 289.22% | 🇮🇱 Israel |
 Alnylam Pharmaceuticals
ALNY | ₹229.21 B | 503.72% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | ₹1.025 T | 2,602.30% | 🇺🇸 USA |
 LabCorp LH | ₹32.16 B | -15.28% | 🇺🇸 USA |
 Ardelyx ARDX | ₹18.63 B | -50.93% | 🇺🇸 USA |